Simona Sacco
A5052696387- Migraine and Headache Studies
- Acute Ischemic Stroke Management
- Trigeminal Neuralgia and Treatments
- Cerebrovascular and Carotid Artery Diseases
- Venous Thromboembolism Diagnosis and Management
- Traumatic Brain Injury and Neurovascular Disturbances
- Atrial Fibrillation Management and Outcomes
- Sympathectomy and Hyperhidrosis Treatments
- Stroke Rehabilitation and Recovery
- Psychosomatic Disorders and Their Treatments
- Intracerebral and Subarachnoid Hemorrhage Research
- Neurological Disorders and Treatments
- Traumatic Brain Injury Research
- Ophthalmology and Eye Disorders
- Cardiovascular Syncope and Autonomic Disorders
- Neurological Complications and Syndromes
- Long-Term Effects of COVID-19
- Cardiac Arrest and Resuscitation
- Olfactory and Sensory Function Studies
- Botulinum Toxin and Related Neurological Disorders
- Antiplatelet Therapy and Cardiovascular Diseases
- Cerebrovascular and genetic disorders
- Intracranial Aneurysms: Treatment and Complications
- Cardiovascular and Diving-Related Complications
- Neurosurgical Procedures and Complications
University of L'Aquila
2016-2025
Marche Polytechnic University
2025
The University of Melbourne
2024
Florey Institute of Neuroscience and Mental Health
2024
National Health and Medical Research Council
2024
Population Health Research Institute
2021-2024
Ospedale San Filippo Neri
2019-2024
National and Kapodistrian University of Athens
2017-2024
Inserm
2021-2024
Université Paris Cité
2021-2024
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
Background and Purpose— Atrial fibrillation (AF) is a major risk factor for ischemic stroke its prevalence increases steeply with age. Population-based data on influence outcome are scarce. Methods— We evaluated the of AF prognosis in patients first-ever from population-based registry. Results— The presence at onset during acute phase was confirmed by standard electrocardiogram 869 (24.6%) 3530 stroke. With respect to without arrhythmia, those were more frequently women, aged 80 years older,...
Background and Purpose— The purpose of this study was to evaluate the incidence prognosis intracerebral hemorrhage. Methods— We analyzed data referring our prospective population-based registry, including patients with a first-ever stroke followed up 10 years. Results— In 5-year period, we included 549 (247 men 302 women; mean age±SD, 73.6±12.5 years) an crude annual rate 36.9 per 100000 (95% CI, 33.8 40.0), 32.9 when standardized 2006 European population, 15.9 world population....
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
Background and Purpose— The best time for administering anticoagulation therapy in acute cardioembolic stroke remains unclear. This prospective cohort study of patients with atrial fibrillation, evaluated (1) the risk recurrent ischemic event severe bleeding; (2) factors recurrence (3) risks bleeding associated anticoagulant its starting after stroke. Methods— primary outcome this multicenter was composite stroke, transient attack, symptomatic systemic embolism, cerebral major extracranial...
Despite advances in the management of headache disorders, some patients with migraine do not experience adequate pain relief acute and preventive treatments. It is aim present document to provide a definition those migraines which are difficult-to-treat, create awareness existence this group patients, help Healthcare Authorities understanding implications, basis develop better pathophysiological support further therapeutic advances.Definitions were established consensus process using Delphi...
Abstract Background We aimed to assess the efficacy and safety of erenumab, a fully human monoclonal antibody inhibiting calcitonin gene-related peptide receptor (CGRPr), for prevention migraine in real-life setting. Main body included our observational study all patients with episodic or chronic treated erenumab during year 2019 Abruzzo region, central Italy, 6-month follow-up. 89 patients; 76 (85.4%) received 6 doses 11 (12.4%) autonomously withdrew drug due perceived inefficacy, 2 (2.2%)...
The purpose of the European Stroke Organisation–Karolinska Update Conference is to provide updates on recent stroke therapy research and give an opportunity for participants discuss how these results may be implemented into clinical routine. meeting started 22 years ago as Karolinska Update, but since 2014 it a joint conference with Organisation. Importantly, provides platform discussion Organisation guidelines process recommendations committee specific topics. By this, adds direct influence...
The optimal blood pressure (BP) management in acute ischaemic stroke (AIS) and intracerebral haemorrhage (ICH) remains controversial. These European Stroke Organisation (ESO) guidelines provide evidence-based recommendations to assist physicians their clinical decisions regarding BP stroke. were developed according the ESO standard operating procedure Grading of Recommendations, Assessment, Development, Evaluation (GRADE) methodology. working group identified relevant questions, performed...